psychedelics Archives

The Countdown to Approval: The Psychedelic Clinical Trials That Could Reshape Mental Healthcare

Multiple late-stage psychedelic trials are currently underway that could transform mental healthcare for millions of Americans.

Cleveland Clinic Study Validates Low Dose Ketamine for Chronic Pain

Cleveland Clinic has published the largest study to date examining low dose ketamine infusions for chronic refractory pain.

Bryan Johnson’s Psilocybin Longevity Experiment: Testing Psychedelics for Anti-Aging

Bryan Johnson, the biohacking entrepreneur known for his extreme anti-aging protocols, said he will test psilocybin as a longevity therapy.

Arizona Launches First Trial Using Whole Psilocybin Mushrooms for PTSD Treatment

Twenty four Arizonans living with post traumatic stress disorder will participate in a groundbreaking study next month.

FDA Program Promises to End Years of Ketamine Shortages for Mental Health Clinics

Phlow Corp. has been selected for the FDA's inaugural Commissioner's National Priority Voucher Pilot Program to manufacture ketamine's active pharmaceutical ingredient domestically.

October 2025 Roundup: What Ketamine Treatment Costs Across the United States

The cost of ketamine therapy continues to evolve. Here's what ketamine treatments cost across the US in October of 2025.

The Psychedelic Pharmaceutical Market Projected to Hit $17B in Next Decade

The global market for these compounds reached $4.75 billion in 2025. Analysts project growth to $16.93 billion by 2034.

A Breakthrough for Depression Treatment: FDA Fast Tracks atai’s Novel Nasal Spray

The FDA has granted Breakthrough Therapy designation to BPL-003, a nasal spray that could transform treatment for patients whose depression resists standard medications.

Gavin Newsom Speeds Psychedelic Research With New Law Backed by Veterans

California Governor Gavin Newsom has signed Assembly Bill 1103, a measure to accelerate the study of psychedelics.

Reimagining End of Life Care: Psychedelic Assisted Therapy Enters the Conversation

New research is shining light on psychedelic assisted therapies as a possible tool to enhance quality of life, ease existential distress, and contain costs.